anti nausea medication for semaglutide TrimRX Frequently Asked Questions | RYBELSUS®

10.2 Lack of direct comparison with emerging therapies Most comparative trials compared tirzepatide against semaglutide at a dose of 1 mg, and head-to-head evaluations with higher doses of semaglutide 2.4 mg (approved for obesity), or with other oral GLP-1 agents are currently lacking

Fatigue accompanies both tirzepatide use and urinary tract infections

Secondary Use : Reducing cardiovascular risks in individuals with both type 2 diabetes and heart disease

Wegovy is approved for chronic weight management in adults who are obese or overweight with at least one weight-related condition such as high blood pressure, type 2 diabetes or high cholesterol